Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

BRTX | BioRestorative Therapies Inc

Index	-	P/E	-	EPS (ttm)	-4.76	Insider Own	20.80%	Shs Outstand	4.67M	Perf Week	-0.01%
Market Cap	7.47M	Forward P/E	-	EPS next Y	-2.46	Insider Trans	4.22%	Shs Float	3.70M	Perf Month	-35.48%
Income	-17.67M	PEG	-	EPS next Q	-0.76	Inst Own	17.16%	Short Float / Ratio	0.53% / 0.30	Perf Quarter	-62.53%
Sales	0.13M	P/S	57.48	EPS this Y	28.86%	Inst Trans	3.03%	Short Interest	0.02M	Perf Half Y	-50.46%
Book/sh	3.11	P/B	0.51	EPS next Y	32.46%	ROA	-107.92%	Target Price	10.50	Perf Year	-34.96%
Cash/sh	2.49	P/C	0.64	EPS next 5Y	-	ROE	-114.03%	52W Range	1.40 - 7.13	Perf YTD	-41.82%
Dividend	-	P/FCF	-	EPS past 5Y	76.38%	ROI	-141.49%	52W High	-77.56%	Beta	60.59
Dividend %	-	Quick Ratio	14.82	Sales past 5Y	26.71%	Gross Margin	-136.59%	52W Low	13.88%	ATR	0.22
Employees	10	Current Ratio	14.82	Sales Q/Q	-9.28%	Oper. Margin	-14153.50%	RSI (14)	38.13	Volatility	10.99% 14.01%
Optionable	No	Debt/Eq	0.02	EPS Q/Q	40.32%	Profit Margin	-13749.53%	Rel Volume	0.24	Prev Close	1.45
Shortable	Yes	LT Debt/Eq	0.01	Earnings	-	Payout	-	Avg Volume	66.19K	Price	1.60
Recom	1.00	SMA20	-10.11%	SMA50	-30.99%	SMA200	-53.39%	Volume	13,013	Change	10.34%

Sep-18-23 09:00AM	Roth MKM Analyst Projects An Impressive Price Target of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says Low Valuation Undeserved (ACCESSWIRE)
Sep-12-23 10:30AM	EXCLUSIVE: Stem Cell Focused BioRestorative Ventures Into $63B Aesthetics Market Via Supply Agreement With Evolutionary Biologics (Benzinga) -12.37%
09:00AM	BioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics (GlobeNewswire)
Sep-08-23 08:30AM	BioRestorative Therapies Announces Activation of Northwell Health in the Company's Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease (GlobeNewswire) -5.40%
Aug-30-23 09:00AM	As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs (ACCESSWIRE)
06:05PM	Loading…
Aug-08-23 06:05PM	Mirati (MRTX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-02-23 09:00AM	BioRestorative Therapies Gains Additional Investor Confidence As Insider Dale Broadrick, CEO Lance Alstodt Purchase Thousands of Shares (ACCESSWIRE)
Jul-31-23 08:05AM	Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform - Insights From The Discussion (ACCESSWIRE)
Jul-26-23 01:01PM	Insider Buying Alert: Lance Alstodt Acquires 4200 Shares of BioRestorative Therapies Inc (BRTX) (GuruFocus.com) +11.73%
Jul-21-23 07:10AM	BioRestorative Therapies (NASDAQ:BRTX) Receives Landmark License From New York State (ACCESSWIRE) -5.32%
Jul-11-23 08:30AM	BioRestorative Therapies Announces $2.1 Million Registered Direct Offering (GlobeNewswire) -13.20%
Jul-07-23 07:00AM	BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities (ACCESSWIRE) -7.26%
Jun-27-23 08:30AM	EXCLUSIVE: Data Monitoring Committee Allows BioRestorative's Chronic Lumbar Disc Disease Study To Continue Unchanged (Benzinga) -23.88%
07:00AM	BioRestorative Therapies Receives Unanimous Recommendation from Data Safety Monitoring Board (DSMB) to Continue its Phase 2 Clinical Trial without any Changes (GlobeNewswire)
Jun-26-23 07:30AM	BioResorative CEO is Featured in An Interview With SmallCaps Daily (NewMediaWire) +13.46%
08:36AM	Loading…
Jun-17-23 08:36AM	Is BioRestorative Therapies (NASDAQ:BRTX) In A Good Position To Invest In Growth? (Simply Wall St.)
Jun-16-23 07:00AM	BioRestorative Therapies, Inc. to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET (GlobeNewswire) +9.65%
Jun-15-23 07:48AM	Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight It (ACCESSWIRE)
Jun-12-23 08:31AM	EXCLUSIVE: BioRestorative Completes Dosing In Safety Cohort Of Chronic Lower Back Pain Trial (Benzinga)
07:00AM	BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease (GlobeNewswire)
Jun-01-23 09:15AM	BioRestorative Therapies, Inc. to attend the Jefferies 2023 Healthcare Conference (GlobeNewswire)
May-31-23 08:30AM	EXCLUSIVE: BioRestorative Therapies Wins License from New York State Department of Health To Act As Tissue Bank for Mesenchymal Stem Cell Processing (Benzinga) -9.09%
07:00AM	BioRestorative Therapies Receives License from New York State Department of Health to act as Tissue Bank for Mesenchymal Stem Cell Processing (GlobeNewswire)
May-15-23 08:31AM	EXCLUSIVE: BioRestorative Therapies' ThermoStem For Metabolic Disorders Expected To Receive Fourth Japanese Patent (Benzinga) +5.40%
07:00AM	BioRestorative Therapies Receives Notice of Allowance by the Japanese Patent and Trademark Office for a Patent Application Related to its ThermoStem® Program (GlobeNewswire)
May-12-23 07:15AM	A New Era In Regenerative Medicine? BioRestorative Therapies (NASDAQ:BRTX) Reports Leading The Expansion Of The Adipose-Derived Stem Cell Therapy Market (ACCESSWIRE)
May-08-23 07:00AM	BioRestorative Therapies and Northwell Health Enter into Agreement to Participate in the Companys Phase 2 Clinical Trial (GlobeNewswire) +17.95%
May-04-23 07:00AM	BioRestorative Therapies, Inc. to participate at the EF Hutton Global Conference May 10-11 in New York City (GlobeNewswire)
Apr-24-23 08:30AM	EXCLUSIVE: BioRestorative Concludes Enrollment For Safety Run-In Component Of Cell Therapy Study For Chronic Lower Back Pain (Benzinga)
07:00AM	BioRestorative Therapies Announces Completion of Patient Enrollment for Safety Run-In Component of its Phase 2 Clinical Study of BRTX-100 (GlobeNewswire)
08:30AM	Loading…
Mar-31-23 08:30AM	BioRestorative Therapies (NASDAQ: BRTX) Is Targeting The Global Obesity Epidemic With Its Recent IP Portfolio Expansion (News Direct)
Mar-28-23 07:01AM	Bullish BioRestorative Therapies, Inc. (NASDAQ:BRTX) insiders filled their treasuries with US$593k worth of stock over last year (Simply Wall St.)
Mar-22-23 09:15AM	What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years? (News Direct)
Mar-13-23 08:30AM	EXCLUSIVE: BioRestorative Seeks Expanded FDA Approval For BRTX-100 Clinical Application, Engages Advisory Firm (Benzinga)
07:00AM	BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100 (GlobeNewswire)
Mar-09-23 06:30AM	BRTXs ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome (News Direct)
Mar-07-23 06:30AM	BioRestorative Therapies to Participate at the 35th Annual ROTH MKM Conference on March 12 -14, 2023 (GlobeNewswire) -9.80%
Mar-02-23 09:00AM	EXCLUSIVE: BioRestorative To Receive Third US Patent For Metabolic ThermoStem Program (Benzinga) +29.39%
07:30AM	BioRestorative Therapies Receives Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its ThermoStem® Program (GlobeNewswire)
Feb-10-23 08:45AM	BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes (News Direct)
Feb-08-23 09:00AM	BioRestorative Therapies Announces Notice of Allowance by the European Patent Office for Patent Related to its ThermoStem® Program (GlobeNewswire)
08:30AM	EXCLUSIVE: BioRestorative Poised To Receive European Patent For ThermoStem Program (Benzinga)
Feb-03-23 09:25AM	BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results (News Direct)
Jan-26-23 08:30AM	2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies (News Direct)
Jan-17-23 09:29AM	BioRestorative Therapies to Present in The Jan 26th Virtual Investor Summit Microcap Event (Newsfile) -9.79%
Dec-06-22 07:00AM	BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem® Targeting Polycystic Ovary Syndrome as an Indication (GlobeNewswire) -6.61%
06:31AM	EXCLUSIVE: BioRestorative Secures Funding Support For Programs Against Polycystic Ovary Syndrome (Benzinga)
Dec-05-22 07:00AM	BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease (GlobeNewswire) -5.33%
06:30AM	EXCLUSIVE: BioRestorative Therapies Gets Exclusive License Rights From Regenexx For Development Of BRTX-100 Disc Program To Treat Chronic Lumbar Disc Disease (Benzinga)
Nov-29-22 11:20AM	BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on Dec. 5-6, 2022 (GlobeNewswire) +5.49%
Nov-16-22 08:56AM	BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022 (GlobeNewswire)
05:16AM	BioRestorative Therapies Third Quarter 2022 Earnings: US$1.28 loss per share (vs US$4.99 loss in 3Q 2021) (Simply Wall St.)
Nov-10-22 08:00AM	The NIH Has Given BioRestorative Therapies A Stamp Of Approval (News Direct) +8.77%
Oct-31-22 08:15AM	See Whats Next For The Regenerative Medicine Field -- BioRestorative Intends to Lead The Pack In Stem Cell Therapies! (News Direct) -5.03%
Oct-20-22 09:30AM	BioRestorative Therapies CEO Lance Alstodt to be Interviewed on Famela and Friends Talk Radio Show (GlobeNewswire)
Oct-14-22 08:00AM	A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field (News Direct)
Sep-28-22 07:00AM	BioRestorative Therapies to Present at the Dawson James Securities 7th Annual Small Cap Growth Conference (GlobeNewswire) +15.04%
Sep-27-22 07:00AM	BioRestorative Therapies to Participate in the Roth Inaugural Healthcare Opportunities Conference (GlobeNewswire)
Sep-07-22 07:00AM	BioRestorative Therapies to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14 (GlobeNewswire)
Sep-01-22 09:00AM	Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst (News Direct)
Aug-25-22 03:49PM	Giving Metabolism A Boost? BioRestorative Uses Science Surrounding Brown Fat Cells To Provide A Possible Breakthrough In Metabolic Disorders (News Direct) +5.58%
Aug-24-22 06:30AM	EXCLUSIVE: BioRestorative Therapies Adds Additional Sites For Lumbar Disc Disease Trial (Benzinga)
Jun-30-22 07:30AM	BioRestorative Therapies Announces First Patient Enrolled for the Companys Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) (GlobeNewswire) -14.24%
Jun-22-22 07:30AM	BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Companys Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) (GlobeNewswire) -12.43%
07:00AM	EXCLUSIVE: BioRestorative Selects Second Site For Its Lumbar Disc Disease Study (Benzinga)
Jun-13-22 07:00AM	BioRestorative Therapies Announces Clinical Site Initiation for the Companys Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) (GlobeNewswire) -6.68%
Apr-29-22 08:00AM	BioRestorative Therapies Hosts Principal Investigator Meeting for its BRTX-100® Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (GlobeNewswire)
Apr-18-22 08:00AM	BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (GlobeNewswire)
Apr-04-22 08:00AM	BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification (GlobeNewswire)
Mar-10-22 08:00AM	BioRestorative Therapies Announces Research Collaboration with Professor Tore Bengtsson to Evaluate Heat Production of its ThermoStem® Program (GlobeNewswire)
Feb-16-22 08:30AM	BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program (GlobeNewswire) +13.65%
Feb-07-22 09:00AM	BioRestorative Therapies Announces it has Initiated its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease Site Selection Underway (GlobeNewswire)
07:45AM	BioRestorative Therapies to Ring Nasdaq Stock Market Closing Bell (GlobeNewswire)
Feb-02-22 08:00AM	BioRestorative Therapies Announces Notice of Allowance for New Patent Application in Japan and Expansion of ThermoStem® IP Portfolio (GlobeNewswire) -5.96%
Jan-26-22 06:00AM	BioRestorative Therapies Named One of Ten Most Innovative Regenerative Medicine Companies in 2022 by Insights Care Magazine (GlobeNewswire)
Jan-11-22 06:00AM	BioRestorative Therapies Announces the Appointment of Robert Paccasassi to Vice President of Quality Assurance/Regulatory Compliance (GlobeNewswire) +5.50%
Jan-06-22 06:00AM	BioRestorative Therapies to Present at H.C. Wainwright BioConnect Virtual Conference (GlobeNewswire) +8.56%
Jan-04-22 06:00AM	BioRestorative Therapies Awarded an STTR Phase I Grant to Explore the Therapeutic Effects of PEG-Peptide Hydrogel-Encapsulated Hypoxic Bone Marrow Stem Cells (GlobeNewswire)
Dec-22-21 07:28AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +17.51%
05:53AM	BioRestorative Stock Surges After Recruiting PRC Clinical As Partner For Lead Product Study (Benzinga)
Dec-21-21 04:01PM	BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (GlobeNewswire)
06:00AM	BioRestorative Therapies CEO Interviewing Live on the James Hicks NewMedia Show (GlobeNewswire)
Dec-20-21 06:00AM	BioRestorative Therapies, Inc. Releases Year-End Message (GlobeNewswire)
Dec-02-21 06:00AM	BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program (GlobeNewswire)
Nov-23-21 04:05PM	WISeKey, Luminaries21.com and OISTE.ORG Foundation signed a strategic agreement to launch high level NFTs for Good by WISe.ART with the support of 1090 worldwide leader members of Luminaries 21 (GlobeNewswire)
Nov-22-21 12:00PM	WISeKey Announces Full Year 2021 Revenue Guidance of $20 Million, an Increase of 32% as Compared to Full Year 2020 (GlobeNewswire) -9.93%
Nov-19-21 12:27PM	WISeKey Strengthens its Smart Card Reader Chips Business for Healthcare Applications and Renews Agreement with HID Global, an ASSA ABLOY Company (GlobeNewswire)
06:00AM	BioRestorative Therapies Enters into Letter of Intent with PRC Clinical (GlobeNewswire)
Nov-10-21 06:00AM	BioRestorative Therapies Appoints Robert Kristal as Chief Financial Officer (GlobeNewswire)
Nov-09-21 02:20PM	BioRestorative Therapies Announces Closing of $23 Million Public Offering (GlobeNewswire) +6.27%
Nov-04-21 09:21PM	BioRestorative Therapies Prices $23 Million Public Offering and Uplisting to the Nasdaq Capital Market (GlobeNewswire)
Oct-26-21 04:05PM	BioRestorative Therapies Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq (GlobeNewswire) -5.71%
08:00AM	BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors (GlobeNewswire)
Sep-23-21 09:00AM	BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program (GlobeNewswire) +9.23%
Sep-02-21 09:00AM	BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program (GlobeNewswire) +31.25%
Aug-31-21 09:00AM	BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem® Program (GlobeNewswire) +6.58%
Aug-19-21 06:00AM	BioRestorative Therapies Awarded One of Top 10 Spine Device Companies by MedTech Outlook (GlobeNewswire)
Aug-11-21 08:30AM	BioRestorative Therapies Discusses Upcoming Annual Meeting of Stockholders (GlobeNewswire)
Aug-09-21 11:58AM	BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering (GlobeNewswire) +8.00%
Jun-07-21 07:00AM	CEO Presenting on the Emerging Growth Conference on June 9. Register here (GlobeNewswire) +13.92%

Biorestorative Therapies Inc. engages in developing therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders including obesity and diabetes. Its initial investigational therapeutic product being called BRTX-100 focuses on treating damage by autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process., The company was founded on June 13, 1997 and is headquartered in Melville, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Broadrick Dale	10% Owner	Sep 15	Buy	1.66	10,000	16,600	327,573	Sep 18 09:20 AM
ALSTODT LANCE	President, CEO, COB	Sep 15	Buy	1.70	2,200	3,740	189,505	Sep 18 09:17 AM
Broadrick Dale	10% Owner	Sep 14	Buy	1.54	10,000	15,400	317,573	Sep 18 09:20 AM
ALSTODT LANCE	President, CEO, COB	Sep 13	Buy	1.53	800	1,226	188,105	Sep 13 05:00 PM
Broadrick Dale	10% Owner	Sep 07	Buy	1.91	1,000	1,910	317,972	Sep 14 04:08 PM
Broadrick Dale	10% Owner	Sep 07	Buy	1.81	1,000	1,810	307,573	Sep 14 04:08 PM
ALSTODT LANCE	President, CEO, COB	Sep 06	Buy	1.96	2,887	5,659	187,305	Sep 06 05:53 PM
Silva Francisco	VP of Research and Development	Aug 31	Buy	2.22	4,954	10,998	164,644	Aug 31 01:54 PM
Broadrick Dale	10% Owner	Jul 28	Buy	2.89	500	1,445	306,573	Sep 14 04:08 PM
Broadrick Dale	10% Owner	Jul 27	Buy	2.80	1,000	2,800	306,073	Jul 28 11:17 AM
ALSTODT LANCE	President, CEO, COB	Jul 25	Buy	2.44	4,200	10,248	184,418	Jul 25 05:56 PM
Silva Francisco	VP of Research and Development	Mar 31	Buy	3.56	747	2,659	159,690	Apr 04 07:00 AM
Broadrick Dale	10% Owner	Feb 22	Buy	2.86	6,000	17,150	305,073	Mar 03 04:11 PM
ALSTODT LANCE	President, CEO, COB	Feb 01	Buy	3.10	400	1,241	187,321	Feb 02 02:49 PM
ALSTODT LANCE	President, CEO, COB	Jan 27	Buy	3.01	200	602	186,921	Jan 30 09:33 AM
ALSTODT LANCE	President, CEO, COB	Jan 20	Buy	3.13	200	627	186,721	Jan 24 12:27 PM
ALSTODT LANCE	President, CEO, COB	Jan 18	Buy	3.11	400	1,244	186,521	Jan 20 08:19 AM
ALSTODT LANCE	President, CEO, COB	Jan 09	Buy	3.08	100	308	186,121	Jan 10 06:06 PM
ALSTODT LANCE	President, CEO, COB	Dec 23	Buy	3.01	300	903	186,021	Dec 28 08:22 AM
ALSTODT LANCE	President, CEO, COB	Dec 07	Buy	2.99	1,800	5,375	185,721	Dec 07 06:04 PM
Broadrick Dale	10% Owner	Nov 30	Buy	2.77	200	555	299,073	Mar 03 04:11 PM
Silva Francisco	VP of Research and Development	Nov 21	Buy	2.62	943	2,467	166,046	Nov 21 05:14 PM
ALSTODT LANCE	President, CEO, COB	Nov 18	Buy	2.88	1,000	2,876	183,921	Nov 21 07:49 AM
Silva Francisco	VP of Research and Development	Oct 12	Buy	3.39	725	2,457	165,103	Oct 12 02:01 PM
Silva Francisco	VP of Research and Development	Oct 11	Buy	3.69	806	2,973	164,378	Oct 12 08:54 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BRTX | BioRestorative Therapies Inc

Upgrade your FINVIZ experience